Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1381 to 1391 of 1391 entries
Sorted by: Best Match Show Resources per page
Covalent organic frameworks: an ideal platform for designing ordered materials and advanced applications.

Chemical Society reviews

Liu R, Tan KT, Gong Y, Chen Y, Li Z, Xie S, He T, Lu Z, Yang H, Jiang D.
PMID: 33283811
Chem Soc Rev. 2021 Jan 07;50(1):120-242. doi: 10.1039/d0cs00620c. Epub 2020 Dec 07.

Covalent organic frameworks offer a molecular platform for integrating organic units into periodically ordered yet extended two- and three-dimensional polymers to create topologically well-defined polygonal lattices and built-in discrete micropores and/or mesopores. This polymer architecture is unique as it...

Cite
Liu R, Tan KT, Gong Y, et al. Covalent organic frameworks: an ideal platform for designing ordered materials and advanced applications. Chem Soc Rev. 2020;50(1):120-242doi: 10.1039/d0cs00620c.
Liu, R., Tan, K. T., Gong, Y., Chen, Y., Li, Z., Xie, S., He, T., Lu, Z., Yang, H., & Jiang, D. (2021). Covalent organic frameworks: an ideal platform for designing ordered materials and advanced applications. Chemical Society reviews, 50(1), 120-242. https://doi.org/10.1039/d0cs00620c
Liu, Ruoyang, et al. "Covalent organic frameworks: an ideal platform for designing ordered materials and advanced applications." Chemical Society reviews vol. 50,1 (2021): 120-242. doi: https://doi.org/10.1039/d0cs00620c
Liu R, Tan KT, Gong Y, Chen Y, Li Z, Xie S, He T, Lu Z, Yang H, Jiang D. Covalent organic frameworks: an ideal platform for designing ordered materials and advanced applications. Chem Soc Rev. 2021 Jan 07;50(1):120-242. doi: 10.1039/d0cs00620c. Epub 2020 Dec 07. PMID: 33283811.
Copy Download .nbib Format: NLM
Combined Impact of Positive Screen for Sarcopenia and Frailty on Physical Function, Cognition and Nutrition in the Community Dwelling Older Adult.

Annals of geriatric medicine and research

Lee HX, Yeo A, Tan CN, Yew S, Tay L, Ding YY, Lim WS.
PMID: 34510882
Ann Geriatr Med Res. 2021 Sep;25(3):210-216. doi: 10.4235/agmr.21.0068. Epub 2021 Sep 13.

BACKGROUND: While sarcopenia and frailty independently contribute to functional impairment and disability, the combined impact resulting from their interplay is unclear. We investigated if functional, physical, cognitive, and nutritional measures were more adversely affected in community-dwelling older adults who...

Cite
Lee HX, Yeo A, Tan CN, et al. Combined Impact of Positive Screen for Sarcopenia and Frailty on Physical Function, Cognition and Nutrition in the Community Dwelling Older Adult. Ann Geriatr Med Res. 2021;25(3):210-216doi: 10.4235/agmr.21.0068.
Lee, H. X., Yeo, A., Tan, C. N., Yew, S., Tay, L., Ding, Y. Y., & Lim, W. S. (2021). Combined Impact of Positive Screen for Sarcopenia and Frailty on Physical Function, Cognition and Nutrition in the Community Dwelling Older Adult. Annals of geriatric medicine and research, 25(3), 210-216. https://doi.org/10.4235/agmr.21.0068
Lee, Hsien Xiong, et al. "Combined Impact of Positive Screen for Sarcopenia and Frailty on Physical Function, Cognition and Nutrition in the Community Dwelling Older Adult." Annals of geriatric medicine and research vol. 25,3 (2021): 210-216. doi: https://doi.org/10.4235/agmr.21.0068
Lee HX, Yeo A, Tan CN, Yew S, Tay L, Ding YY, Lim WS. Combined Impact of Positive Screen for Sarcopenia and Frailty on Physical Function, Cognition and Nutrition in the Community Dwelling Older Adult. Ann Geriatr Med Res. 2021 Sep;25(3):210-216. doi: 10.4235/agmr.21.0068. Epub 2021 Sep 13. PMID: 34510882; PMCID: PMC8497951.
Copy Download .nbib Format: NLM
Sustained-Release and pH-Adjusted Alginate Microspheres-Encapsulated Doxorubicin Inhibit the Viabilities in Hepatocellular Carcinoma-Derived Cells.

Pharmaceutics

Pan CT, Yu RS, Yang CJ, Chen LR, Wen ZH, Chen NY, Ou HY, Yu CY, Shiue YL.
PMID: 34575492
Pharmaceutics. 2021 Sep 07;13(9). doi: 10.3390/pharmaceutics13091417.

The objective of this study aimed to develop biodegradable calcium alginate microspheres carrying doxorubicin (Dox) at the micrometer-scale for sustained release and the capacity of pH regulatory for transarterial chemoembolization. Ultrasonic atomization and CaCl

Cite
Pan CT, Yu RS, Yang CJ, et al. Sustained-Release and pH-Adjusted Alginate Microspheres-Encapsulated Doxorubicin Inhibit the Viabilities in Hepatocellular Carcinoma-Derived Cells. Pharmaceutics. 2021;13(9)doi: 10.3390/pharmaceutics13091417.
Pan, C. T., Yu, R. S., Yang, C. J., Chen, L. R., Wen, Z. H., Chen, N. Y., Ou, H. Y., Yu, C. Y., & Shiue, Y. L. (2021). Sustained-Release and pH-Adjusted Alginate Microspheres-Encapsulated Doxorubicin Inhibit the Viabilities in Hepatocellular Carcinoma-Derived Cells. Pharmaceutics, 13(9), . https://doi.org/10.3390/pharmaceutics13091417
Pan, Cheng-Tang, et al. "Sustained-Release and pH-Adjusted Alginate Microspheres-Encapsulated Doxorubicin Inhibit the Viabilities in Hepatocellular Carcinoma-Derived Cells." Pharmaceutics vol. 13,9 (2021). doi: https://doi.org/10.3390/pharmaceutics13091417
Pan CT, Yu RS, Yang CJ, Chen LR, Wen ZH, Chen NY, Ou HY, Yu CY, Shiue YL. Sustained-Release and pH-Adjusted Alginate Microspheres-Encapsulated Doxorubicin Inhibit the Viabilities in Hepatocellular Carcinoma-Derived Cells. Pharmaceutics. 2021 Sep 07;13(9). doi: 10.3390/pharmaceutics13091417. PMID: 34575492; PMCID: PMC8471522.
Copy Download .nbib Format: NLM
Plasmon-enhanced reduced graphene oxide photodetector with monometallic of Au and Ag nanoparticles at VIS-NIR region.

Scientific reports

Rohizat NS, Ripain AHA, Lim CS, Tan CL, Zakaria R.
PMID: 34608217
Sci Rep. 2021 Oct 04;11(1):19688. doi: 10.1038/s41598-021-99189-w.

Hybrids plasmonic nanoparticles (NPs) and unique 2D graphene significantly enhanced the photoresponse of the photodetectors. The metallic NPs that exhibit localized surface plasmon resonance (LSPR) improves strong light absorption, scattering and localized electromagnetic field by the incident photons depending...

Cite
Rohizat NS, Ripain AHA, Lim CS, et al. Plasmon-enhanced reduced graphene oxide photodetector with monometallic of Au and Ag nanoparticles at VIS-NIR region. Sci Rep. 2021;11(1):19688doi: 10.1038/s41598-021-99189-w.
Rohizat, N. S., Ripain, A. H. A., Lim, C. S., Tan, C. L., & Zakaria, R. (2021). Plasmon-enhanced reduced graphene oxide photodetector with monometallic of Au and Ag nanoparticles at VIS-NIR region. Scientific reports, 11(1), 19688. https://doi.org/10.1038/s41598-021-99189-w
Rohizat, Nurul Syazwani, et al. "Plasmon-enhanced reduced graphene oxide photodetector with monometallic of Au and Ag nanoparticles at VIS-NIR region." Scientific reports vol. 11,1 (2021): 19688. doi: https://doi.org/10.1038/s41598-021-99189-w
Rohizat NS, Ripain AHA, Lim CS, Tan CL, Zakaria R. Plasmon-enhanced reduced graphene oxide photodetector with monometallic of Au and Ag nanoparticles at VIS-NIR region. Sci Rep. 2021 Oct 04;11(1):19688. doi: 10.1038/s41598-021-99189-w. PMID: 34608217; PMCID: PMC8490468.
Copy Download .nbib Format: NLM
Characterization of Piezoelectric Properties of Ag-NPs Doped PVDF Nanocomposite Fibres Membrane Prepared by Near Field Electrospinning.

Combinatorial chemistry & high throughput screening

Pan CT, Dutt K, Yen CK, Kumar A, Kaushik AC, Wei DQ, Kumar A, Wen ZH, Hsu WH, Shiue YL.
PMID: 33653246
Comb Chem High Throughput Screen. 2021 Mar 01; doi: 10.2174/1386207324666210302100728. Epub 2021 Mar 01.

BACKGROUND: In this study, Near-field electrospinning (NFES) technique used with a cylindrical collector to fabricate a large area permanent piezoelectric micro and nanofibers by a prepared solution. NFES requires a small electric field to fabricate fibers.OBJECTIVE: The objective of...

Cite
Pan CT, Dutt K, Yen CK, et al. Characterization of Piezoelectric Properties of Ag-NPs Doped PVDF Nanocomposite Fibres Membrane Prepared by Near Field Electrospinning. Comb Chem High Throughput Screen. 2021;doi: 10.2174/1386207324666210302100728.
Pan, C. T., Dutt, K., Yen, C. K., Kumar, A., Kaushik, A. C., Wei, D. Q., Kumar, A., Wen, Z. H., Hsu, W. H., & Shiue, Y. L. (2021). Characterization of Piezoelectric Properties of Ag-NPs Doped PVDF Nanocomposite Fibres Membrane Prepared by Near Field Electrospinning. Combinatorial chemistry & high throughput screening, . https://doi.org/10.2174/1386207324666210302100728
Pan, Cheng-Tang, et al. "Characterization of Piezoelectric Properties of Ag-NPs Doped PVDF Nanocomposite Fibres Membrane Prepared by Near Field Electrospinning." Combinatorial chemistry & high throughput screening vol. (2021). doi: https://doi.org/10.2174/1386207324666210302100728
Pan CT, Dutt K, Yen CK, Kumar A, Kaushik AC, Wei DQ, Kumar A, Wen ZH, Hsu WH, Shiue YL. Characterization of Piezoelectric Properties of Ag-NPs Doped PVDF Nanocomposite Fibres Membrane Prepared by Near Field Electrospinning. Comb Chem High Throughput Screen. 2021 Mar 01; doi: 10.2174/1386207324666210302100728. Epub 2021 Mar 01. PMID: 33653246.
Copy Download .nbib Format: NLM
Robust estimates of regional treatment effects in multiregional randomized clinical trials with semiparametric logistic model.

Pharmaceutical statistics

Yuan A, Yang C, Yu S, Tan MT.
PMID: 34350678
Pharm Stat. 2021 Aug 04; doi: 10.1002/pst.2157. Epub 2021 Aug 04.

In multiregional randomized clinical trials (MRCTs), determining the regional treatment effect of a new treatment over an existing one is important to both the sponsor and related regulatory agencies. Also of particular interest is to test the null hypothesis...

Cite
Yuan A, Yang C, Yu S, et al. Robust estimates of regional treatment effects in multiregional randomized clinical trials with semiparametric logistic model. Pharm Stat. 2021;doi: 10.1002/pst.2157.
Yuan, A., Yang, C., Yu, S., & Tan, M. T. (2021). Robust estimates of regional treatment effects in multiregional randomized clinical trials with semiparametric logistic model. Pharmaceutical statistics, . https://doi.org/10.1002/pst.2157
Yuan, Ao, et al. "Robust estimates of regional treatment effects in multiregional randomized clinical trials with semiparametric logistic model." Pharmaceutical statistics vol. (2021). doi: https://doi.org/10.1002/pst.2157
Yuan A, Yang C, Yu S, Tan MT. Robust estimates of regional treatment effects in multiregional randomized clinical trials with semiparametric logistic model. Pharm Stat. 2021 Aug 04; doi: 10.1002/pst.2157. Epub 2021 Aug 04. PMID: 34350678.
Copy Download .nbib Format: NLM
Transplantable programmed death ligand 1 expressing gastroids from gastric cancer prone Nfkb1.

Cell death & disease

Low JT, Ho GY, Scott M, Tan CW, Whitehead L, Barber K, Yip HYK, Dekkers JF, Hirokawa Y, Silke J, Burgess AW, Strasser A, Putoczki TL, O'Reilly LA.
PMID: 34789734
Cell Death Dis. 2021 Nov 17;12(12):1091. doi: 10.1038/s41419-021-04376-2.

No abstract available.

Cite
Low JT, Ho GY, Scott M, et al. Transplantable programmed death ligand 1 expressing gastroids from gastric cancer prone Nfkb1. Cell Death Dis. 2021;12(12):1091doi: 10.1038/s41419-021-04376-2.
Low, J. T., Ho, G. Y., Scott, M., Tan, C. W., Whitehead, L., Barber, K., Yip, H. Y. K., Dekkers, J. F., Hirokawa, Y., Silke, J., Burgess, A. W., Strasser, A., Putoczki, T. L., & O'Reilly, L. A. (2021). Transplantable programmed death ligand 1 expressing gastroids from gastric cancer prone Nfkb1. Cell death & disease, 12(12), 1091. https://doi.org/10.1038/s41419-021-04376-2
Low, Jun T, et al. "Transplantable programmed death ligand 1 expressing gastroids from gastric cancer prone Nfkb1." Cell death & disease vol. 12,12 (2021): 1091. doi: https://doi.org/10.1038/s41419-021-04376-2
Low JT, Ho GY, Scott M, Tan CW, Whitehead L, Barber K, Yip HYK, Dekkers JF, Hirokawa Y, Silke J, Burgess AW, Strasser A, Putoczki TL, O'Reilly LA. Transplantable programmed death ligand 1 expressing gastroids from gastric cancer prone Nfkb1. Cell Death Dis. 2021 Nov 17;12(12):1091. doi: 10.1038/s41419-021-04376-2. PMID: 34789734; PMCID: PMC8599488.
Copy Download .nbib Format: NLM
Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation.

Journal of inorganic biochemistry

Peng YB, Tao C, Tan CP, Zhao P.
PMID: 33684684
J Inorg Biochem. 2021 May;218:111400. doi: 10.1016/j.jinorgbio.2021.111400. Epub 2021 Feb 25.

Recently, rhodium complexes have received intensive attentions due to their tunable chemical and biological properties as well as attractive antitumor activity. In this work, two imidazole triphenylamino rhodium complexes [Rh(ppy)

Cite
Peng YB, Tao C, Tan CP, et al. Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation. J Inorg Biochem. 2021;218:111400doi: 10.1016/j.jinorgbio.2021.111400.
Peng, Y. B., Tao, C., Tan, C. P., & Zhao, P. (2021). Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation. Journal of inorganic biochemistry, 218111400. https://doi.org/10.1016/j.jinorgbio.2021.111400
Peng, Yan-Bo, et al. "Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation." Journal of inorganic biochemistry vol. 218 (2021): 111400. doi: https://doi.org/10.1016/j.jinorgbio.2021.111400
Peng YB, Tao C, Tan CP, Zhao P. Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation. J Inorg Biochem. 2021 May;218:111400. doi: 10.1016/j.jinorgbio.2021.111400. Epub 2021 Feb 25. PMID: 33684684.
Copy Download .nbib Format: NLM
Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore.

Thrombosis journal

Tan CW, Fan BE, Teo WZY, Tung ML, Shafi H, Christopher D, Zheng S, Peh WM, Chan SSW, Chong VCL, Gallardo CA, Chang CCR, Ling LM, Tan JY, Lee KCH, Phua GC, Cherng BPZ, Low JGH, Ho VK, Prasad V, Wong LJL, Lim CXQ, Chee YL, Ong KH, Lee LH, Ng HJ, Yap ES.
PMID: 33685477
Thromb J. 2021 Mar 08;19(1):14. doi: 10.1186/s12959-021-00268-9.

BACKGROUND: Arterial and venous thrombosis are reported to be common in critically ill COVID-19 patients.METHOD AND RESULTS: This is a national multicenter retrospective observational study involving all consecutive adult COVID-19 patients who required intensive care units (ICU) admission between...

Cite
Tan CW, Fan BE, Teo WZY, et al. Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore. Thromb J. 2021;19(1):14doi: 10.1186/s12959-021-00268-9.
Tan, C. W., Fan, B. E., Teo, W. Z. Y., Tung, M. L., Shafi, H., Christopher, D., Zheng, S., Peh, W. M., Chan, S. S. W., Chong, V. C. L., Gallardo, C. A., Chang, C. C. R., Ling, L. M., Tan, J. Y., Lee, K. C. H., Phua, G. C., Cherng, B. P. Z., Low, J. G. H., Ho, V. K., Prasad, V., Wong, L. J. L., Lim, C. X. Q., Chee, Y. L., Ong, K. H., Lee, L. H., Ng, H. J., Yap, E. S. (2021). Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore. Thrombosis journal, 19(1), 14. https://doi.org/10.1186/s12959-021-00268-9
Tan, Chuen Wen, et al. "Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore." Thrombosis journal vol. 19,1 (2021): 14. doi: https://doi.org/10.1186/s12959-021-00268-9
Tan CW, Fan BE, Teo WZY, Tung ML, Shafi H, Christopher D, Zheng S, Peh WM, Chan SSW, Chong VCL, Gallardo CA, Chang CCR, Ling LM, Tan JY, Lee KCH, Phua GC, Cherng BPZ, Low JGH, Ho VK, Prasad V, Wong LJL, Lim CXQ, Chee YL, Ong KH, Lee LH, Ng HJ, Yap ES. Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore. Thromb J. 2021 Mar 08;19(1):14. doi: 10.1186/s12959-021-00268-9. PMID: 33685477; PMCID: PMC7938262.
Copy Download .nbib Format: NLM
Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?.

Journal of molecular medicine (Berlin, Germany)

Weng CH, Wu RC, Chen SJ, Chen HC, Tan KT, Lee YS, Huang SS, Yang LY, Wang CJ, Chou HH, Chao AS, Chao A, Lai CH.
PMID: 33768299
J Mol Med (Berl). 2021 Jul;99(7):959-966. doi: 10.1007/s00109-021-02064-4. Epub 2021 Mar 25.

Synchronous endometrial and ovarian carcinomas (SEOCs) that share the same endometrioid histology are generally considered as the result of metastatic spread from one organ to another. However, SEOCs with different histologies are regarded as distinct primary lesions that arise...

Cite
Weng CH, Wu RC, Chen SJ, et al. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?. J Mol Med (Berl). 2021;99(7):959-966doi: 10.1007/s00109-021-02064-4.
Weng, C. H., Wu, R. C., Chen, S. J., Chen, H. C., Tan, K. T., Lee, Y. S., Huang, S. S., Yang, L. Y., Wang, C. J., Chou, H. H., Chao, A. S., Chao, A., & Lai, C. H. (2021). Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?. Journal of molecular medicine (Berlin, Germany), 99(7), 959-966. https://doi.org/10.1007/s00109-021-02064-4
Weng, Cindy Hsuan, et al. "Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?." Journal of molecular medicine (Berlin, Germany) vol. 99,7 (2021): 959-966. doi: https://doi.org/10.1007/s00109-021-02064-4
Weng CH, Wu RC, Chen SJ, Chen HC, Tan KT, Lee YS, Huang SS, Yang LY, Wang CJ, Chou HH, Chao AS, Chao A, Lai CH. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?. J Mol Med (Berl). 2021 Jul;99(7):959-966. doi: 10.1007/s00109-021-02064-4. Epub 2021 Mar 25. PMID: 33768299.
Copy Download .nbib Format: NLM
A vaccine targeting mutant IDH1 in newly diagnosed glioma.

Nature

Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F, Sanghvi K, Tan CL, Poschke I, Green E, Justesen S, Behrens GA, Breckwoldt MO, Freitag A, Rother LM, Schmitt A, Schnell O, Hense J, Misch M, Krex D, Stevanovic S, Tabatabai G, Steinbach JP, Bendszus M, von Deimling A, Schmitt M, Wick W.
PMID: 33762734
Nature. 2021 Apr;592(7854):463-468. doi: 10.1038/s41586-021-03363-z. Epub 2021 Mar 24.

Mutated isocitrate dehydrogenase 1 (IDH1) defines a molecularly distinct subtype of diffuse glioma

Cite
Platten M, Bunse L, Wick A, et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature. 2021;592(7854):463-468doi: 10.1038/s41586-021-03363-z.
Platten, M., Bunse, L., Wick, A., Bunse, T., Le Cornet, L., Harting, I., Sahm, F., Sanghvi, K., Tan, C. L., Poschke, I., Green, E., Justesen, S., Behrens, G. A., Breckwoldt, M. O., Freitag, A., Rother, L. M., Schmitt, A., Schnell, O., Hense, J., Misch, M., Krex, D., Stevanovic, S., Tabatabai, G., Steinbach, J. P., Bendszus, M., von Deimling, A., Schmitt, M., & Wick, W. (2021). A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature, 592(7854), 463-468. https://doi.org/10.1038/s41586-021-03363-z
Platten, Michael, et al. "A vaccine targeting mutant IDH1 in newly diagnosed glioma." Nature vol. 592,7854 (2021): 463-468. doi: https://doi.org/10.1038/s41586-021-03363-z
Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F, Sanghvi K, Tan CL, Poschke I, Green E, Justesen S, Behrens GA, Breckwoldt MO, Freitag A, Rother LM, Schmitt A, Schnell O, Hense J, Misch M, Krex D, Stevanovic S, Tabatabai G, Steinbach JP, Bendszus M, von Deimling A, Schmitt M, Wick W. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature. 2021 Apr;592(7854):463-468. doi: 10.1038/s41586-021-03363-z. Epub 2021 Mar 24. PMID: 33762734; PMCID: PMC8046668.
Copy Download .nbib Format: NLM
Showing 1381 to 1391 of 1391 entries